Detalhe da pesquisa
1.
Archival single-cell genomics reveals persistent subclones during DCIS progression.
Cell
; 186(18): 3968-3982.e15, 2023 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37586362
2.
Ductal carcinoma in situ develops within clonal fields of mutant cells in morphologically normal ducts.
J Pathol
; 263(3): 360-371, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38779852
3.
Artificial intelligence-based morphometric signature to identify ductal carcinoma in situ with low risk of progression to invasive breast cancer.
Res Sq
; 2023 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38168198
4.
A living biobank of patient-derived ductal carcinoma in situ mouse-intraductal xenografts identifies risk factors for invasive progression.
Cancer Cell
; 41(5): 986-1002.e9, 2023 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37116492
5.
Homologous recombination deficiency derived from whole-genome sequencing predicts platinum response in triple-negative breast cancers.
Nat Commun
; 14(1): 1958, 2023 04 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37029129
6.
Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types.
Hum Mutat
; 33(1): 100-3, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22009941
7.
The Snf1-related kinase, Hunk, is essential for mammary tumor metastasis.
Proc Natl Acad Sci U S A
; 106(37): 15855-60, 2009 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19717424
8.
Comprehensive characterization of pre- and post-treatment samples of breast cancer reveal potential mechanisms of chemotherapy resistance.
NPJ Breast Cancer
; 8(1): 60, 2022 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35523804
9.
Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer.
Nat Genet
; 54(6): 850-860, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35681052
10.
Chromogenic in situ hybridisation for the assessment of HER2 status in breast cancer: an international validation ring study.
Breast Cancer Res
; 9(5): R68, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17922920
11.
Gene expression profiles of primary breast carcinomas from patients at high risk for local recurrence after breast-conserving therapy.
Clin Cancer Res
; 12(19): 5705-12, 2006 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17020974
12.
Mechanisms of Therapy Resistance in Patient-Derived Xenograft Models of BRCA1-Deficient Breast Cancer.
J Natl Cancer Inst
; 108(11)2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27381626
13.
Expression of the breast cancer resistance protein in breast cancer.
Clin Cancer Res
; 8(4): 1068-74, 2002 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-11948115
14.
Multidrug resistance associated genes MRP1, MRP2 and MRP3 in primary and anthracycline exposed breast cancer.
Anticancer Res
; 24(5A): 2931-9, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15517899
15.
Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patients.
Clin Cancer Res
; 16(2): 651-63, 2010 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20068109
16.
Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomas.
J Pathol
; 201(1): 75-82, 2003 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-12950019